Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07829185 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer

Study acronym: FALCON
StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this research is to observe the effects of using a new combination of drugs to inhibit tumor growth.
Trial Details
NCT Number NCT07829185
Lead Sponsor University of Oklahoma
Conditions
(from sponsor)		 Pancreatic Ductal Adenocarcinoma (PDAC)
Related terms Neoplasm Metastasis
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov